Evidence map›Paper›PMID 32480312›Full record

ReviewCurrent opinion in plant biology2020

It's Morphin' time: how multiple signals converge on ARF transcription factors to direct development.

Amy Lanctot, Jennifer L Nemhauser

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in plant biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
16.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Plants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Effects ofPlants (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Structural Aspects of Auxin Signaling.Cold Spring Harbor perspectives in biology · 2022
    Review
  11. Article
  12. Casting the Net-Connecting Auxin Signaling to the Plant Genome.Cold Spring Harbor perspectives in biology · 2021
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amy LanctotDepartment of Biology, University of Washington, Seattle, WA 98195, United States; Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, United States.
Jennifer L NemhauserDepartment of Biology, University of Washington, Seattle, WA 98195, United States. Electronic address: jn7@uw.edu.
University of Washington · US

Funding

Control of protein degradation dynamics in the auxin responseR01GM107084 · NIGMS · UNIVERSITY OF WASHINGTON · PI NEMHAUSER, JENNIFER L · 2014 to 2022
$2.4M
NIGMS NIH HHS R01 GM107084
6 · The paper itself

Abstract

Plant development programs are constantly updated by information about environmental conditions, currently available resources, and sites of active organogenesis. Much of this information is encoded in modifications of transcription factors that lead to changes in their relative abundance, activity and localization. Recent work on the Auxin Response Factor family of transcription factors has highlighted the large diversity of such modifications, as well as how they may work synergistically or antagonistically to regulate downstream responses. ARFs can be regulated by alternative splicing, post-translational modification, and subcellular localization, among many other mechanisms. Beyond the many ways ARFs themselves can be regulated, they can also act cooperatively with other transcription factors to enable highly complex genetic networks with distinct developmental outcomes. Multi-level regulation like what has been documented for ARFs has the capacity to generate flexibility in transcriptional outputs, as well as resilience to short-term perturbations.

Indexed as

Gene Expression Regulation, PlantTranscription FactorsAlternative SplicingIndoleacetic AcidsPlant DevelopmentIndoleacetic AcidsTranscription Factors

Identifiers

PMID32480312
PMCPMC7704782
OpenAlexW3032656105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.